Gene · 92140
Papers2,305
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,305
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MTDH∆7-mediated mTOR activation drives doxorubicin resistance in triple-negative breast cancer: Relevance of mTORC1 inhibition on chemosensitization. | Cell Signal | 2025 | 40373843 | PubTator, text mining | PubMed |
| Elucidating the interaction between MTDH, an oncoprotein with UPR signalling molecule IRE1α under cellular stress. | J Biomol Struct Dyn | 2025 | 40286277 | PubTator, text mining | PubMed |
| Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH): A Promising Molecular Marker and Therapeutic Target for Hepatocellular Carcinoma. | Cancers (Basel) | 2025 | 40282551 | PubTator, text mining | PubMed |
| MicroRNA-122 overexpression suppresses the colon cancer cell proliferation by downregulating the astrocyte elevated gene-1/metadherin oncoprotein. | Ann Med | 2025 | 40208016 | PubTator, text mining | PubMed |
| Effects of Induced Pluripotent Stem Cell-Derived Astrocytes on Cisplatin Sensitivity in Pediatric Brain Cancer Cells. | Cancers (Basel) | 2025 | 40149331 | PubTator, text mining | PubMed |
| Research and progress of microRNA-136 in metastatic tumors. | Front Oncol | 2025 | 40104500 | PubTator, text mining | PubMed |
| Targeting ADAR1 with a small molecule for the treatment of prostate cancer. | Nat Cancer | 2025 | 39930013 | PubTator, text mining | PubMed |
| Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein-Protein Interaction. | J Med Chem | 2025 | 39792778 | PubTator, text mining | PubMed |
| Ubiquitin and Ubiquitin-Like Modifications in Organelle Stress Signaling: Ub, Ub, Ub, Ub, Stayin' Alive, Stayin' Alive. | Bioessays | 2025 | 39600056 | PubTator, text mining | PubMed |
| linc01152 Regulates Cell Viability, Cell Migration and Cell Invasion of Breast Cancer via Regulating miR-320a and MTDH. | Biochem Genet | 2025 | 38847869 | PubTator, text mining | PubMed |
| The Role of Zuo Jin Wan in Modulating the Tumor Microenvironment of Colorectal Cancer. | Comb Chem High Throughput Screen | 2025 | 38284730 | PubTator, text mining | PubMed |
| microRNA-875-5p-conjugated gold nanoparticles suppress breast cancer progression through the MTDH/PTEN/AKT signaling pathway. | Discov Oncol | 2024 | 39692921 | PubTator, text mining | PubMed |
| LncRNA DDX11-AS1 promotes breast cancer progression by targeting the miR-30c-5p/MTDH axis. | Sci Rep | 2024 | 39501057 | PubTator, text mining | PubMed |
| mRNA-seq-based analysis predicts: AEG-1 is a therapeutic target and immunotherapy biomarker for pan-cancer, including OSCC. | Front Immunol | 2024 | 39483471 | PubTator, text mining | PubMed |
| A Study on the Binding Mechanism and the Impact of Key Residue Mutations between SND1 and MTDH Peptide through Molecular Dynamics Simulations. | J Phys Chem B | 2024 | 39276108 | PubTator, text mining | PubMed |
| The role of RRS1 in breast cancer cells metastasis and AEG-1/AKT/c-Myc signaling pathway. | Neoplasma | 2024 | 39267538 | PubTator, text mining | PubMed |
| miR-30d Attenuates Pulmonary Arterial Hypertension via Targeting MTDH and PDE5A and Modulates the Beneficial Effect of Sildenafil. | Adv Sci (Weinh) | 2024 | 39206778 | PubTator, text mining | PubMed |
| OLFM4 modulates intestinal inflammation by promoting IL-22+ILC3 in the gut. | Commun Biol | 2024 | 39075283 | PubTator, text mining | PubMed |
| MiR-30c suppresses the proliferation, metastasis and polarity reversal of tumor cell clusters by targeting MTDH in invasive micropapillary carcinoma of the breast. | Heliyon | 2024 | 39071710 | PubTator, text mining | PubMed |
| Ovatodiolide inhibited hepatocellular carcinoma stemness through SP1/MTDH/STAT3 signaling pathway. | Chem Biol Interact | 2024 | 39053793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92140/papers?page=4